Dose Escalated Liver Stereotactic Body Radiation Therapy at the Mean Respiratory Position

• Published in: International journal of radiation oncology, biology, physics Vol. 89; no. 5; pp. 1121 - 1128
• Main Authors: Velec, Michael, PhD, Moseley, Joanne L., BMath, Dawson, Laura A., MD, Brock, Kristy K., PhD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2014
• Subjects: COMPARATIVE EVALUATIONS; COMPUTERIZED TOMOGRAPHY; Cone-Beam Computed Tomography; Exhalation; Four-Dimensional Computed Tomography; Hematology, Oncology and Palliative Medicine; Humans; LIVER; Liver Neoplasms - pathology; Liver Neoplasms - secondary; Liver Neoplasms - surgery; Movement; NEOPLASMS; PATIENTS; PLANNING; Probability; RADIATION DOSES; Radiology; RADIOLOGY AND NUCLEAR MEDICINE; Radiosurgery - methods; RADIOTHERAPY; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted - methods; Radiotherapy, Intensity-Modulated; RESPIRATION; Retrospective Studies; Tumor Burden
• ISSN: 0360-3016; 1879-355X
• DOI: 10.1016/j.ijrobp.2014.04.051

Purpose The dosimetric impact of dose probability based planning target volume (PTV) margins for liver cancer patients receiving stereotactic body radiation therapy (SBRT) was compared with standard PTV based on the internal target volume (ITV). Plan robustness was evaluated by accumulating the treatment dose to ensure delivery of the intended plan. Methods and Materials Twenty patients planned on exhale CT for 27 to 50 Gy in 6 fractions using an ITV-based PTV and treated free-breathing were retrospectively evaluated. Isotoxic, dose escalated plans were created on midposition computed tomography (CT), representing the mean breathing position, using a dose probability PTV. The delivered doses were accumulated using biomechanical deformable registration of the daily cone beam CT based on liver targeting at the exhale or mean breathing position, for the exhale and midposition CT plans, respectively. Results The dose probability PTVs were on average 38% smaller than the ITV-based PTV, enabling an average ± standard deviation increase in the planned dose to 95% of the PTV of 4.0 ± 2.8 Gy (9 ± 5%) on the midposition CT ( P <.01). For both plans, the delivered minimum gross tumor volume (GTV) doses were greater than the planned nominal prescribed dose in all 20 patients and greater than the planned dose to 95% of the PTV in 18 (90%) patients. Nine patients (45%) had 1 or more GTVs with a delivered minimum dose more than 5 Gy higher with the midposition CT plan using dose probability PTV, compared with the delivered dose with the exhale CT plan using ITV-based PTV. Conclusions For isotoxic liver SBRT planned and delivered at the mean respiratory, reduced dose probability PTV enables a mean escalation of 4 Gy (9%) in 6 fractions over ITV-based PTV. This may potentially improve local control without increasing the risk of tumor underdosing.